Seaport Therapeutics

top of page

State of Possible: On the one-year anniversary of the spin-out of Seaport Therapeutics, Daphne Zohar describes the Glyph platform that powers it, and her thoughts on running depression trials

She describes the idea of leveraging Glyph to achieve oral dosing of medicines in cases where it would not be possible or tolerable....

Company News

Mar 26

Daphne Zohar on becoming the CEO of Seaport Therapeutics and today's $100M series A

She describes working with Steven Paul again, the Glyph technology that is the backbone of Seaport's platform, and more.

Company News

Apr 9, 2024

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.

Learn more about Allucent

bottom of page

State of Possible: On the one-year anniversary of the spin-out of Seaport Therapeutics, Daphne Zohar describes the Glyph platform that powers it, and her thoughts on running depression trials

Daphne Zohar on becoming the CEO of Seaport Therapeutics and today's $100M series A

Follow BiotechTV

Sponsors

Sponsor Spotlight